Skip to content
2000
Volume 26, Issue 8
  • ISSN: 1389-2002
  • E-ISSN: 1875-5453

Abstract

Licochalcone A (LCA) is an important secondary metabolite in licorice that has attracted extensive attention due to its unique species-specific distribution characteristics and various pharmacodynamic activities, particularly its anti-inflammatory and anti-cancer effects. LCA was originally considered exclusive to Batal. However, further analyses have shown its distribution in different licorice species, extending its known distribution among licorice species and suggesting a broader role in secondary metabolism. Nevertheless, the complex chemical synthesis of LCA presents challenges in regioselectivity control. The oral bioavailability of LCA is limited due to the intestinal first-pass effect, and its metabolic mechanism has not yet been fully elucidated. These issues restrict the therapeutic effects and practical applications of LCA . In recent years, advancements in optimizing synthetic pathways and developing new delivery systems have significantly improved the efficacy of LCA while also achieving notable breakthroughs in its safety. This review examines the distribution patterns, synthesis methods, metabolic processes, pharmacological activities, and current application status of LCA, while also exploring future research directions. However, its metabolic mechanisms and prospects for clinical application still require further investigation in the future. A multi-source database search related literature employed “Licochalcone A”as the anchor term, synergized with species taxonomy (), biogeographic patterns, and phytochemical dynamics (biosynthesis/metabolism).

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdm/10.2174/0113892002380407250730080035
2025-08-25
2026-02-23

  • From This Site

    /content/journals/cdm/10.2174/0113892002380407250730080035
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BishtD. RashidM. AryaR.K.K. KumarD. ChaudharyS.K. RanaV.S. SethiyaN.K. Revisiting liquorice (Glycyrrhiza glabra L.) as anti-inflammatory, antivirals and immunomodulators: Potential pharmacological applications with mechanistic insight.Phytomed. Plus20222110020610.1016/j.phyplu.2021.100206 35403088
     [Google Scholar]
  2. WonS.R. KimS.K. KimY.M. LeeP.H. RyuJ.H. KimJ.W. RheeH.I. LicochalconeA. Licochalcone A: A lipase inhibitor from the roots of Glycyrrhiza uralensis.Food Res. Int.20074081046105010.1016/j.foodres.2007.05.005
     [Google Scholar]
  3. LiM.T. XieL. JiangH.M. HuangQ. TongR.S. LiX. XieX. LiuH.M. Role of licochalcone A in potential pharmacological therapy: A review.Front. Pharmacol.20221387877610.3389/fphar.2022.878776 35677438
     [Google Scholar]
  4. BhatiaH.S. ApweilerM. SunL. BaronJ. TirkeyA. FiebichB.L. LicochalconeA. Licochalcone A inhibits prostaglandin E2 by targeting the MAPK pathway in LPS activated primary microglia.Molecules2023284192710.3390/molecules28041927 36838914
     [Google Scholar]
  5. de FreitasK.S. SquarisiI.S. AcésioN.O. NicolellaH.D. OzelinS.D. Reis Santos de MeloM. GuissoneA.P.P. FernandesG. SilvaL.M. da Silva FilhoA.A. TavaresD.C. Licochalcone A, a licorice flavonoid: Antioxidant, cytotoxic, genotoxic, and chemopreventive potential.J. Toxicol. Environ. Health A20208321-2267368610.1080/15287394.2020.1813228 32886024
     [Google Scholar]
  6. LiuM. DuY. GaoD. Licochalcone A: A review of its pharmacology activities and molecular mechanisms.Front. Pharmacol.202415145342610.3389/fphar.2024.1453426 39188947
     [Google Scholar]
  7. FaragM.A. PorzelA. WessjohannL.A. Comparative metabolite profiling and fingerprinting of medicinal licorice roots using a multiplex approach of GC–MS, LC–MS and 1D NMR techniques.Phytochemistry201276607210.1016/j.phytochem.2011.12.010 22336263
     [Google Scholar]
  8. BaiM. YaoG.D. RenQ. LiQ. LiuQ.B. ZhangY. WangX.B. HuangX.X. SongS.J. Triterpenoid saponins and flavonoids from licorice residues with anti-inflammatory activity.Ind. Crops Prod.2018125125505810.1016/j.indcrop.2018.08.075
     [Google Scholar]
  9. DaoT.T.H. LinthorstH.J.M. VerpoorteR. Chalcone synthase and its functions in plant resistance.Phytochem. Rev.201110339741210.1007/s11101‑011‑9211‑7 21909286
     [Google Scholar]
  10. YinY. ZhangX. GaoZ. HuT. LiuY. The research progress of chalcone isomerase (CHI) in plants.Mol. Biotechnol.2019611325210.1007/s12033‑018‑0130‑3 30324542
     [Google Scholar]
  11. WuZ. SinghS.K. LyuR. PattanaikS. WangY. LiY. YuanL. LiuY. Metabolic engineering to enhance the accumulation of bioactive flavonoids licochalcone A and echinatin in Glycyrrhiza inflata (Licorice) hairy roots.Front Plant. Sci.20221393259410.3389/fpls.2022.932594 36061790
     [Google Scholar]
  12. LiuJ. ZhuZ. YangY. Adu-FrimpongM. ChenL. JiH. ToreniyazovE. WangQ. YuJ. XuX. Preparation, characterization, pharmacokinetics, and antirenal injury activity studies of Licochalcone A‐loaded liposomes.J. Food Biochem.20224611400710.1111/jfbc.14007 34811762
     [Google Scholar]
  13. WuW. WangZ. WuY. WuH. ChenT. XueY. WangY. JiangC. ShenC. LiuL. ZhuH. LiuQ. Mechanisms of penetration enhancement and transport utilizing skin keratine liposomes for the topical delivery of licochalcone A.Molecules2022278250410.3390/molecules27082504 35458701
     [Google Scholar]
  14. PageM.J. MoherD. BossuytP.M. BoutronI. HoffmannT.C. MulrowC.D. ShamseerL. TetzlaffJ.M. AklE.A. BrennanS.E. ChouR. GlanvilleJ. GrimshawJ.M. HróbjartssonA. LaluM.M. LiT. LoderE.W. Mayo-WilsonE. McDonaldS. McGuinnessL.A. StewartL.A. ThomasJ. TriccoA.C. WelchV.A. WhitingP. McKenzieJ.E. PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews.BMJ2021372n16010.1136/bmj.n160 33781993
     [Google Scholar]
  15. WangH. LiL. QingX. ZhangS. LiS. Efficacy of Qishen Yiqi drop pill for chronic heart failure: An updated meta-analysis of 85 studies.Cardiovasc. Ther.2020202011410.1155/2020/8138764 33042225
     [Google Scholar]
  16. WangM. ShanY. WuC. CaoP. SunW. HanJ. ShenL. ChenJ. YuP. ChenX. Efficacy and safety of Qishen Yiqi dripping pill for heart failure with preserved ejection fraction: A systematic review and meta-analysis.Front. Pharmacol.20211162637510.3389/fphar.2020.626375 33633570
     [Google Scholar]
  17. YangL. LiuY.L. LinS.Q. HPLC analysis of flavonoids in the root of six Glycyrrhiza species.Yao Xue Xue Bao19902511840848 2099092
     [Google Scholar]
  18. WangH. SongW. TaoW. ZhangJ. ZhangX. ZhaoJ. YongJ. GaoX. GuoL. Identification wild and cultivated licorice by multidimensional analysis.Food Chem.202033912811110.1016/j.foodchem.2020.128111 33152888
     [Google Scholar]
  19. SimmlerC. AndersonJ.R. GauthierL. LankinD.C. McAlpineJ.B. ChenS.N. PauliG.F. Metabolite profiling and classification of DNA-authenticated licorice botanicals.J. Nat. Prod.20157882007202210.1021/acs.jnatprod.5b00342 26244884
     [Google Scholar]
  20. HatanoT. KagawaH. YasuharaT. OkudaT. Two new flavonoids and other constituents in licorice root. Their relative astringency and radical scavenging effects.Chem. Pharm. Bull.19883662090209710.1248/cpb.36.2090 3240445
     [Google Scholar]
  21. ZhaoJ. WangM. AdamsS.J. LeeJ. ChittiboyinaA.G. AvulaB. AliZ. RamanV. LiJ. WuC. KhanI.A. Metabolite variation and discrimination of five licorice (Glycyrrhiza) species: HPTLC and NMR explorations.J. Pharm. Biomed. Anal.202222011501210.1016/j.jpba.2022.115012 36041397
     [Google Scholar]
  22. HeR. MaT. GongM. XieK. WangZ. LiJ. The correlation between pharmacological activity and contents of eight constituents of Glycyrrhiza uralensis Fisch.Heliyon2023931457010.1016/j.heliyon.2023.e14570 36967897
     [Google Scholar]
  23. El-Saber BatihaG. Magdy BeshbishyA. El-MleehA. Abdel-DaimM.M. Prasad DevkotaH. Traditional uses, bioactive chemical constituents, and pharmacological and toxicological activities of Glycyrrhiza glabra L. (Fabaceae).Biomolecules202010335210.3390/biom10030352 32106571
     [Google Scholar]
  24. SongW. QiaoX. ChenK. WangY. JiS. FengJ. LiK. LinY. YeM. Biosynthesis-based quantitative analysis of 151 secondary metabolites of licorice to differentiate medicinal Glycyrrhiza species and their hybrids.Anal. Chem.20178953146315310.1021/acs.analchem.6b04919 28192986
     [Google Scholar]
  25. MontoroP. MaldiniM. RussoM. PostorinoS. PiacenteS. PizzaC. Metabolic profiling of roots of liquorice (Glycyrrhiza glabra) from different geographical areas by ESI/MS/MS and determination of major metabolites by LC-ESI/MS and LC-ESI/MS/MS.J. Pharm. Biomed. Anal.201154353554410.1016/j.jpba.2010.10.004 21041055
     [Google Scholar]
  26. BaiH. BaoF. FanX. HanS. ZhengW. SunL. YanN. DuH. ZhaoH. YangZ. Metabolomics study of different parts of licorice from different geographical origins and their anti‐inflammatory activities.J. Sep. Sci.20204381593160210.1002/jssc.201901013 32032980
     [Google Scholar]
  27. YuC. ZhengQ. WangX. SunJ. WeiN. SunX. ZhangY. XieJ. Evaluation of the differences of sour jujuba fruits from diverse regions based on the collaborative analysis of organic acids and flavor characters.Rev. Bras. Farmacogn.202535122423710.1007/s43450‑024‑00611‑x
     [Google Scholar]
  28. ShangZ. TianY. YiY. LiK. QiaoX. YeM. Comparative bioactivity evaluation and chemical profiling of different parts of the medicinal plant Glycyrrhiza uralensis.J. Pharm. Biomed. Anal.202221521511479310.1016/j.jpba.2022.114793 35489249
     [Google Scholar]
  29. CelanoR. DocimoT. PiccinelliA.L. RizzoS. CamponeL. Di SanzoR. CarabettaS. RastrelliL. RussoM. Specialized metabolite profiling of different Glycyrrhiza glabra organs by untargeted UHPLC-HRMS.Ind. Crops Prod.202117011368810.1016/j.indcrop.2021.113688
     [Google Scholar]
  30. RashaH.B. ZeinatK. AhmedM. EmanS. Antimicrobial potential of licorice: Leaves versus roots.Afr. J. Microbiol. Res.20126497485749310.5897/AJMR12.1182
     [Google Scholar]
  31. ZhaoC. WangF. LianY. XiaoH. ZhengJ. Biosynthesis of citrus flavonoids and their health effects.Crit. Rev. Food Sci. Nutr.202060456658310.1080/10408398.2018.1544885 30580548
     [Google Scholar]
  32. LiY. ZhuangF. ZengJ. YangC. LiY. LuoM. WangY. Identification of the histone demethylases gene family in Glycyrrhiza inflata reveals genes responding to abiotic stresses.J. Cell. Biochem.2022123111780179210.1002/jcb.30315 35933705
     [Google Scholar]
  33. ZengJ. HuangY. ZhouL. LiangX. YangC. WangH. YuanL. WangY. LiY. Histone deacetylase GiSRT2 negatively regulates flavonoid biosynthesis in Glycyrrhiza inflata.Cells20231211150110.3390/cells12111501 37296622
     [Google Scholar]
  34. VijayalakshmiU. ShourieA. Yeast extract-mediated elicitation of anti-cancerous compounds licoisoflavone B, licochalcone A, and liquirtigenin in callus cultures of Glycyrrhiza glabra.Biotechnologia2019100444145110.5114/bta.2019.90245
     [Google Scholar]
  35. NaikJ. MisraP. TrivediP.K. PandeyA. Molecular components associated with the regulation of flavonoid biosynthesis.Plant Sci.202231711119610.1016/j.plantsci.2022.111196 35193745
     [Google Scholar]
  36. LiuW. FengY. YuS. FanZ. LiX. LiJ. YinH. The flavonoid biosynthesis network in plants.Int. J. Mol. Sci.202122231282410.3390/ijms222312824 34884627
     [Google Scholar]
  37. LiY. XieZ. HuangY. ZengJ. YangC. YuanL. WangY. LiY. Integrated metabolomic and transcriptomic analysis provides insights into the flavonoid formation in different Glycyrrhiza species.Ind. Crops Prod.202420811779610.1016/j.indcrop.2023.117796
     [Google Scholar]
  38. AimiuwuJ. WangH. ChenP. XieZ. WangJ. LiuS. KlisovicR. MimsA. BlumW. MarcucciG. ChanK.K. RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia.Blood2012119225229523810.1182/blood‑2011‑11‑382226 22517893
     [Google Scholar]
  39. MaX. JiangN. FuJ. LiY. ZhouL. YuanL. WangY. LiY. A cytosine analogue 5-azacitidine improves the accumulation of licochalcone A in licorice Glycyrrhiza inflata.J. Plant Physiol.202429215414510.1016/j.jplph.2023.154145 38091890
     [Google Scholar]
  40. ZhangZ. YangJ. WangX. WangY. LiuR. ChenW. LiH. Content determination of licoflavone and licochalcone A in Licorice residues and optimization in extraction and purification process.Chem. Bioen20244112556110.3969/j.issn.1672‑5425.2024.12.009
     [Google Scholar]
  41. JunJ-G. JeonJ-H. KimM. Concise synthesis of licochalcone A through water-accelerated [3, 3]-sigmatropic rearrangement of an aryl prenyl ether.Synthesis20112011337037610.1055/s‑0030‑1258381
     [Google Scholar]
  42. LiW. ZhangY. TianN. XieJ. Exploring the protective effects of Spinosin against advanced glycation end product-induced cellular damage through modulation RAGE/MAPK/NF-κB pathway.Food Biosci.20256410595110.1016/j.fbio.2025.105951
     [Google Scholar]
  43. ZhangY. LiW. HouP. YangT. XieJ. Physicochemical and stability analysis of mung bean protein hydrolysates with lipid peroxidation inhibition.Food Chem.2025463Pt 114113510.1016/j.foodchem.2024.141135 39255708
     [Google Scholar]
  44. KwonH.S. ParkJ.H. KimD.H. KimY.H. ParkJ.H.Y. ShinH.K. KimJ.K. Licochalcone A isolated from licorice suppresses lipopolysaccharide-stimulated inflammatory reactions in RAW264.7 cells and endotoxin shock in mice.J. Mol. Med.200886111287129510.1007/s00109‑008‑0395‑2 18825356
     [Google Scholar]
  45. KolbeL. ImmeyerJ. BatzerJ. WensorraU. DieckK. MundtC. WolberR. StäbF. SchönrockU. CeilleyR.I. WenckH. Anti-inflammatory efficacy of Licochalcone A: Correlation of clinical potency and in vitro effects.Arch. Dermatol. Res.20062981233010.1007/s00403‑006‑0654‑4 16552540
     [Google Scholar]
  46. KontogiorgisC. MantzanidouM. Hadjipavlou-LitinaD. Chalcones and their potential role in inflammation.Mini Rev. Med. Chem.20088121224124210.2174/138955708786141034 18855737
     [Google Scholar]
  47. MontiS. ManetI. ManoliF. MarconiG. Structure and properties of licochalcone A–human serum albumin complexes in solution: A spectroscopic, photophysical and computational approach to understand drug–protein interaction.Phys. Chem. Chem. Phys.200810446597660610.1039/b809241a 18989470
     [Google Scholar]
  48. Funakoshi-TagoM. NakamuraK. TsuruyaR. HatanakaM. MashinoT. SonodaY. KasaharaT. The fixed structure of Licochalcone A by α, β-unsaturated ketone is necessary for anti-inflammatory activity through the inhibition of NF-κB activation.Int. Immunopharmacol.201010556257110.1016/j.intimp.2010.02.003 20153843
     [Google Scholar]
  49. ZhuangC. ZhangW. ShengC. ZhangW. XingC. MiaoZ. Chalcone: A privileged structure in medicinal chemistry.Chem. Rev.2017117127762781010.1021/acs.chemrev.7b00020 28488435
     [Google Scholar]
  50. YangG. LeeH.E. YeonS.H. KangH.C. ChoY.Y. LeeH.S. ZouboulisC.C. HanS.H. LeeJ.H. LeeJ.Y. Licochalcone A attenuates acne symptoms mediated by suppression of NLRP3 inflammasome.Phytother. Res.201832122551255910.1002/ptr.6195 30281174
     [Google Scholar]
  51. CargnelloM. RouxP.P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.Microbiol. Mol. Biol. Rev.2011751508310.1128/MMBR.00031‑10 21372320
     [Google Scholar]
  52. CuiY. AoM. HuJ. YuL. YuL. Anti-inflammatory activity of licochalcone A isolated from Glycyrrhiza inflata.Z. Naturforsch. C J. Biosci.2008635-636136510.1515/znc‑2008‑5‑609 18669021
     [Google Scholar]
  53. CaiM. XuY. DengB. ChenJ.B. ChenT.F. ZengK.F. ChenS. DengS. TanZ. DingW. ZhangS. LiuB. ZhangJ. Radix Glycyrrhizae extract and licochalcone a exert an antiinflammatory action by direct suppression of toll like receptor 4.J. Ethnopharmacol2023302Pt A11586910.1016/j.jep.2022.11586936309116
     [Google Scholar]
  54. SongN. KimJ.E. ParkJ. KimJ. KangH. LeeE. KangY.G. SonJ. SeoS. HeoY. LeeK. Licochalcone A, a polyphenol present in licorice, suppresses UV-induced COX-2 expression by targeting PI3K, MEK1, and B-Raf.Int. J. Mol. Sci.20151634453447010.3390/ijms16034453 25710724
     [Google Scholar]
  55. ChuX. CiX. WeiM. YangX. CaoQ. GuanM. LiH. DengY. FengH. DengX. Licochalcone a inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo.J. Agric. Food Chem.201260153947395410.1021/jf2051587 22400806
     [Google Scholar]
  56. TanifujiS. Aizu-YokotaE. Funakoshi-TagoM. SonodaY. InoueH. KasaharaT. Licochalcones suppress degranulation by decreasing the intracellular Ca2+ level and tyrosine phosphorylation of ERK in RBL-2H3 cells.Int. Immunopharmacol.201010776977610.1016/j.intimp.2010.04.007 20399908
     [Google Scholar]
  57. PhanH.T.L. KimH.J. JoS. KimW.K. NamkungW. NamJ.H. Anti-inflammatory effect of licochalcone a via regulation of ORAI1 and K+ channels in T-Lymphocytes.Int. J. Mol. Sci.202122191084710.3390/ijms221910847 34639190
     [Google Scholar]
  58. HuangW.C. LiuC.Y. ShenS.C. ChenL.C. YehK.W. LiuS.H. LiouC.J. Protective effects of licochalcone A improve airway hyper-responsiveness and oxidative stress in a mouse model of asthma.Cells20198661710.3390/cells8060617 31226782
     [Google Scholar]
  59. RafiM.M. RosenR.T. VassilA. HoC.T. ZhangH. GhaiG. LambertG. DiPaolaR.S. Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid.Anticancer Res.200020426532658 10953339
     [Google Scholar]
  60. YoY.T. ShiehG.S. HsuK.F. WuC.L. ShiauA.L. Licorice and licochalcone-A induce autophagy in LNCaP prostate cancer cells by suppression of Bcl-2 expression and the mTOR pathway.J. Agric. Food Chem.200957188266827310.1021/jf901054c 19711916
     [Google Scholar]
  61. LinR.C. YangS.F. ChiouH.L. HsiehS.C. WenS.H. LuK.H. HsiehY.H. Licochalcone A-induced apoptosis through the activation of p38MAPK pathway mediated mitochondrial pathways of apoptosis in human osteosarcoma cells in vitro and in vivo.Cells2019811144110.3390/cells8111441 31739642
     [Google Scholar]
  62. YuanL.W. JiangX.M. XuY.L. HuangM.Y. ChenY.C. YuW.B. SuM.X. YeZ.H. ChenX. WangY. LuJ.J. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.Phytomedicine20218015339410.1016/j.phymed.2020.153394 33130472
     [Google Scholar]
  63. LiuX. XingY. LiM. ZhangZ. WangJ. RiM. JinC. XuG. PiaoL. JinH. ZuoH. MaJ. JinX. Licochalcone A inhibits proliferation and promotes apoptosis of colon cancer cell by targeting programmed cell death-ligand 1 via the NF-κB and Ras/Raf/MEK pathways.J. Ethnopharmacol.202127311398910.1016/j.jep.2021.113989 33677006
     [Google Scholar]
  64. ChuangC.Y. TangC.M. HoH.Y. HsinC.H. WengC.J. YangS.F. ChenP.N. LinC.W. Licochalcone A induces apoptotic cell death via JNK/p38 activation in human nasopharyngeal carcinoma cells.Environ. Toxicol.201934785386010.1002/tox.22753 30983163
     [Google Scholar]
  65. KangT.H. SeoJ.H. OhH. YoonG. ChaeJ.I. ShimJ.H. Licochalcone A suppresses specificity protein 1 as a novel target in human breast cancer cells.J. Cell. Biochem.2017118124652466310.1002/jcb.26131 28498645
     [Google Scholar]
  66. ShenT.S. HsuY.K. HuangY.F. ChenH.Y. HsiehC.P. ChenC.L. Licochalcone A suppresses the proliferation of osteosarcoma cells through autophagy and ATM-Chk2 activation.Molecules20192413243510.3390/molecules24132435 31269698
     [Google Scholar]
  67. TsaiJ.P. LeeC.H. YingT.H. LinC.L. LinC.L. HsuehJ.T. HsiehY.H. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.Oncotarget2015630288512886610.18632/oncotarget.4767 26311737
     [Google Scholar]
  68. XiaoX. HaoM. YangX. BaQ. LiM. NiS. WangL.S. DuX. Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis.Cancer Lett.20113021697510.1016/j.canlet.2010.12.016 21216524
     [Google Scholar]
  69. LiuR. WenX. ShaoF. ZhangP. HuangH. ZhangS. Flavonoids from heartwood of Dalbergia cochinchinensis.Chin. Herb. Med.201681899310.1016/S1674‑6384(16)60014‑X
     [Google Scholar]
  70. LepetsosP. PapavassiliouA.G. ROS/oxidative stress signaling in osteoarthritis.Biochim. Biophys. Acta Mol. Basis Dis.20161862457659110.1016/j.bbadis.2016.01.003 26769361
     [Google Scholar]
  71. HaoW. YuanX. YuL. GaoC. SunX. WangD. ZhengQ. Licochalcone A-induced human gastric cancer BGC-823 cells apoptosis by regulating ROS-mediated MAPKs and PI3K/AKT signaling pathways.Sci. Rep.2015511033610.1038/srep10336 25981581
     [Google Scholar]
  72. HuangC.F. YangS.F. ChiouH.L. HsuW.H. HsuJ.C. LiuC.J. HsiehY.H. Licochalcone A inhibits the invasive potential of human glioma cells by targeting the MEK/ERK and ADAM9 signaling pathways.Food Funct.20189126196620410.1039/C8FO01643G 30465574
     [Google Scholar]
  73. HuJ. LiuJ. Licochalcone A attenuates lipopolysaccharide-induced acute kidney injury by inhibiting NF-κB activation.Inflammation201639256957410.1007/s10753‑015‑0281‑3 26552405
     [Google Scholar]
  74. HaraguchiH. IshikawaH. MizutaniK. TamuraY. KinoshitaT. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata.Bioorg. Med. Chem.19986333934710.1016/S0968‑0896(97)10034‑7 9568287
     [Google Scholar]
  75. OlloquequiJ. EttchetoM. CanoA. FortunaA. BickerJ. Sánchez-LopezE. PazC. UreñaJ. VerdaguerE. AuladellC. CaminsA. LicochalconeA. Licochalcone A: A potential multitarget drug for Alzheimer’s disease treatment.Int. J. Mol. Sci.202324181417710.3390/ijms241814177 37762479
     [Google Scholar]
  76. AraI. TurcioR. IslamT. HossainM.S. HasanM.K. Anti-aging related activities and health benefits of Licochalcone A: A review.Clin. Complement. Med. Pharmacol.20244110012510.1016/j.ccmp.2023.100125
     [Google Scholar]
  77. MishraL.C. BhattacharyaA. BhasinV.K. Phytochemical licochalcone A enhances antimalarial activity of artemisinin in vitro in vivo.Acta Trop.2009109319419810.1016/j.actatropica.2008.11.006 19063856
     [Google Scholar]
  78. KlotzM. OpperS. HeegK. ZimmermannS. Detection of Staphylococcus aureus enterotoxins A to D by real-time fluorescence PCR assay.J. Clin. Microbiol.200341104683468710.1128/JCM.41.10.4683‑4687.2003 14532203
     [Google Scholar]
  79. QiuJ. FengH. XiangH. WangD. XiaL. JiangY. SongK. LuJ. YuL. DengX. Influence of subinhibitory concentrations of licochalcone A on the secretion of enterotoxins A and B by Staphylococcus aureus.FEMS Microbiol. Lett.2010307213514110.1111/j.1574‑6968.2010.01973.x 20412304
     [Google Scholar]
  80. NadelmannL. TjørnelundJ. HansenS.H. CornettC. SidelmannU.G. BraumannU. ChristensenE. ChristensenS.B. Synthesis, isolation and identification of glucuronides and mercapturic acids of a novel antiparasitic agent, licochalcone A.Xenobiotica199727766768010.1080/004982597240262 9253144
     [Google Scholar]
  81. SoarsM.G. BurchellB. RileyR.J. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.J. Pharmacol. Exp. Ther.2002301138239010.1124/jpet.301.1.382 11907196
     [Google Scholar]
  82. ZhangD. ZhuM. HumphreysW. Drug Metabolism in Drug Design and Development: Basic Concepts and Practice200710.1002/9780470191699
     [Google Scholar]
  83. NaritomiY. NakamoriF. FurukawaT. TabataK. Prediction of hepatic and intestinal glucuronidation using in vitro–in vivo extrapolation.Drug Metab. Pharmacokinet.2015301212910.1016/j.dmpk.2014.10.001 25760528
     [Google Scholar]
  84. HendersonM.C. MirandaC.L. StevensJ.F. DeinzerM.L. BuhlerD.R. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus.Xenobiotica200030323525110.1080/004982500237631 10752639
     [Google Scholar]
  85. ObachR.S. WalskyR.L. VenkatakrishnanK. Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions.Drug Metab. Dispos.200735224625510.1124/dmd.106.012633 17093004
     [Google Scholar]
  86. NebertD.W. WikvallK. MillerW.L. Human cytochromes P450 in health and disease.Philos. Trans. R. Soc. Lond. B Biol. Sci.201336816122012043110.1098/rstb.2012.0431 23297354
     [Google Scholar]
  87. HuangL. NikolicD. van BreemenR.B. Hepatic metabolism of licochalcone A, a potential chemopreventive chalcone from licorice (Glycyrrhiza inflata), determined using liquid chromatography-tandem mass spectrometry.Anal. Bioanal. Chem.2017409306937694810.1007/s00216‑017‑0642‑x 29127460
     [Google Scholar]
  88. LiT. YeW. HuangB. LuX. ChenX. LinY. WenC. WangX. Determination and pharmacokinetic study of echinatin by UPLC-MS/MS in rat plasma.J. Pharm. Biomed. Anal.201916813313710.1016/j.jpba.2019.02.023 30807917
     [Google Scholar]
  89. XiaY.L. DouT.Y. LvX. GeG.B. In vitro characterization of the glucuronidation pathways of licochalcone A mediated by human UDP-glucuronosyltransferases.Xenobiotica201949667167710.1080/00498254.2018.1495345 30044687
     [Google Scholar]
  90. XinH. QiX.Y. WuJ.J. WangX.X. LiY. HongJ.Y. HeW. XuW. GeG.B. YangL. Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases.Food Chem. Toxicol.20169011212210.1016/j.fct.2016.02.007 26875642
     [Google Scholar]
  91. MinersJ.O. BowalgahaK. ElliotD.J. BaranczewskiP. KnightsK.M. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: Application to the reaction phenotyping of acetaminophen glucuronidation.Drug Metab. Dispos.201139464465210.1124/dmd.110.037036 21245288
     [Google Scholar]
  92. BernardO. GuillemetteC. The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants.Drug Metab. Dispos.200432877577810.1124/dmd.32.8.775 15258099
     [Google Scholar]
  93. HigashiE. AndoA. IwanoS. MurayamaN. YamazakiH. MiyamotoY. Hepatic microsomal UDP‐glucuronosyltransferase (UGT) activities in the microminipig.Biopharm. Drug Dispos.201435631332010.1002/bdd.1898 24752421
     [Google Scholar]
  94. RauchensteinerF. MatsumuraY. YamamotoY. YamajiS. TaniT. Analysis and comparison of Radix Glycyrrhizae (licorice) from Europe and China by capillary-zone electrophoresis (CZE).J. Pharm. Biomed. Anal.200538459460010.1016/j.jpba.2005.01.038 15967286
     [Google Scholar]
  95. NadelmannL. TjørnelundJ. ChristensenE. HansenS.H. High-performance liquid chromatographic determination of licochalcone A and its metabolites in biological fluids.J. Chromatogr., Biomed. Appl.1997695238940010.1016/S0378‑4347(97)00189‑8 9300876
     [Google Scholar]
  96. ChoiJ.S. ChoiJ.S. ChoiD.H. Effects of licochalcone A on the bioavailability and pharmacokinetics of nifedipine in rats: possible role of intestinal CYP3A4 and P‐gp inhibition by licochalcone A.Biopharm. Drug Dispos.201435738239010.1002/bdd.1905 24903704
     [Google Scholar]
  97. WengQ. ChenL. YeL. LuX. YuZ. WenC. ChenY. HuangG. Determination of licochalcone A in rat plasma by UPLC–MS/MS and its pharmacokinetics.Acta Chromatogr.201931426226510.1556/1326.2018.00491
     [Google Scholar]
  98. LinH. SuM. WenC. TangY. LiH. WuY. GeR. LiX. LinH. Chalcones from plants cause toxicity by inhibiting human and rat 11β-hydroxysteroid dehydrogenase 2: 3D-quantitative structure-activity relationship (3D-QSAR) and in silico docking analysis.Food Chem. Toxicol.202418411441510.1016/j.fct.2023.114415 38141941
     [Google Scholar]
  99. YuanC. LuZ. JinZ. Characterization of an inclusion complex of ethyl benzoate with hydroxypropyl-β-cyclodextrin.Food Chem.201415214014510.1016/j.foodchem.2013.11.139 24444918
     [Google Scholar]
  100. RamirezH.L. ValdiviaA. CaoR. FragosoA. Torres LabandeiraJ.J. BañosM. VillalongaR. Preparation of β-cyclodextrin-dextran polymers and their use as supramolecular carrier systems for naproxen.Polym. Bull.200759559760510.1007/s00289‑007‑0803‑8
     [Google Scholar]
  101. WuJ. WangK. WangX. PangY. JiangC. The role of the gut microbiome and its metabolites in metabolic diseases.Protein Cell202112536037310.1007/s13238‑020‑00814‑7 33346905
     [Google Scholar]
  102. MittalA. KakkarR. Synthetic methods and biological applications of retrochalcones isolated from the root of Glycyrrhiza species: A review.Results Chem.2021310021610.1016/j.rechem.2021.100216
     [Google Scholar]
  103. MehrniaM.A. JafariS.M. Makhmal-ZadehB.S. MaghsoudlouY. Crocin loaded nano-emulsions: Factors affecting emulsion properties in spontaneous emulsification.Int. J. Biol. Macromol.20168426126710.1016/j.ijbiomac.2015.12.029 26708427
     [Google Scholar]
  104. Jalali JivanM. AbbasiS. Nano based lutein extraction from marigold petals: Optimization using different surfactants and co-surfactants.Heliyon2019540157210.1016/j.heliyon.2019.e01572 31183433
     [Google Scholar]
  105. LiY. NingJ. WangY. WangC. SunC. HuoX. YuZ. FengL. ZhangB. TianX. MaX. Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects.Toxicol. Lett.2018294273610.1016/j.toxlet.2018.05.008 29753067
     [Google Scholar]
  106. ZhuZ. LiuJ. YangY. Adu-FrimpongM. JiH. ToreniyazovE. WangQ. YuJ. XuX. SMEDDS for improved oral bioavailability and anti-hyperuricemic activity of licochalcone A.J. Microencapsul.2021387-845947110.1080/02652048.2021.1963341 34338606
     [Google Scholar]
  107. AlnasrauiA.H.F. JoeI.H. Al-MusawiS. Design and synthesize of folate decorated Fe3O4@Au-DEX-CP nano formulation for targeted drug delivery in colorectal cancer therapy: In vitro and in vivo studies.J. Drug Deliv. Sci. Technol.20238710479810.1016/j.jddst.2023.104798
     [Google Scholar]
  108. KimuraY. ItoH. OhnishiR. HatanoT. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity.Food Chem. Toxicol.201048142943510.1016/j.fct.2009.10.041 19883715
     [Google Scholar]
  109. SpaggiariD. GeiserL. DaaliY. RudazS. Phenotyping of CYP450 in human liver microsomes using the cocktail approach.Anal. Bioanal. Chem.2014406204875488710.1007/s00216‑014‑7915‑4 24894520
     [Google Scholar]
  110. GuengerichF.P. Roles of individual human cytochrome P450 enzymes in drug metabolism.Pharmacol. Rev.20247661104113210.1124/pharmrev.124.001173 39054072
     [Google Scholar]
  111. HeW. WuJ.J. NingJ. HouJ. XinH. HeY.Q. GeG.B. XuW. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.Toxicol. In vitro20152971569157610.1016/j.tiv.2015.06.014 26100226
     [Google Scholar]
  112. LiG. SimmlerC. ChenL. NikolicD. ChenS.N. PauliG.F. van BreemenR.B. Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents.Eur. J. Pharm. Sci.201710918219010.1016/j.ejps.2017.07.034 28774812
     [Google Scholar]
/content/journals/cdm/10.2174/0113892002380407250730080035
Loading
Comprehensive Insights into Licochalcone A: its Distribution, Biosynthesis, Metabolism, and Pharmacological Effects
Current Drug Metabolism 26, 548 (2025); https://doi.org/10.2174/0113892002380407250730080035
/content/journals/cdm/10.2174/0113892002380407250730080035
/content/journals/cdm/10.2174/0113892002380407250730080035
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): biosynthesis; distribution; Licochalcone A; metabolism; pharmacological effects; safety evaluation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test